Zhejiang Qianjiang Biochemical adds $100M guarantee for high-debt subsidiary
What's the deal? Zhejiang Qianjiang BiochemicalDealroom has a profile for this one. Try Dealroom → said on August 7, 2026, that it will provide a joint liability guarantee of up to $100 million for its wholly owned sub-subsidiary, Haining Tianyuan Water Supply and Drainage Engineering MaterialsDealroom has a profile for this one. Try Dealroom →. The pledge, signed with the Haining branch of China Construction BankDealroom has a profile for this one. Try Dealroom →, covers credit facilities over the next year.
The numbers: With this addition, Tianyuan's total guaranteed amount reaches $350 million, leaving $90 million in remaining quota. The guarantee carries no counter-guarantee measures, meaning Zhejiang Qianjiang Biochemical bears the full risk.
What could go wrong? Tianyuan is heavily indebted. Its debt ratio stood at about 88.7% at the end of 2025 and 87.1% by March 31, 2026 — well above the 70% warning line the company flagged. If Tianyuan cannot repay its bank debt, Zhejiang Qianjiang Biochemical faces direct pressure on its cash flow and profits.
The wider exposure: Zhejiang Qianjiang Biochemical and its subsidiaries now carry total external guarantees of RMB 1.651 billion, or 44.55% of the company's most recent audited net assets. Of that, guarantees to consolidated subsidiaries total RMB 1.399 billion. The company reported no overdue guarantees.
Why now? Tianyuan runs construction, engineering supply, municipal facility management, and environmental equipment operations. It posted net profit of RMB 28.87 million in 2025, but just RMB 2.46 million in the first quarter of 2026, underscoring thin earnings against a large debt load.
The process: The company's board approved the 2026 guarantee limits on April 16, 2026, and shareholders ratified them on May 12, 2026, both by unanimous vote. The guarantee falls within the estimated limit approved at the 2025 annual shareholders' meeting.
The signal: The deal is procedurally clean but financially heavy. Backstopping a subsidiary whose debt ratio nears 90% — with no fallback protection — ties a growing share of Zhejiang Qianjiang Biochemical's net assets to a fragile borrower, a risk investors will watch as Tianyuan's balance sheet evolves.
Read more: Minichart
Image credit: Generated with Gemini
